In October 2023, Structure Therapeutics Inc. closed the transaction. The company has disclosed the placement agent expenses of $17,999,999.721 in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.52 USD | -2.18% |
|
-5.04% | +16.58% |
Jun. 07 | Structure Therapeutics Closes $547.4 Million Offering | MT |
Jun. 07 | BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.58% | 2.26B | |
+14.84% | 122B | |
+18.31% | 113B | |
+3.61% | 22.66B | |
-18.26% | 21.34B | |
-41.55% | 16.92B | |
-14.23% | 16.68B | |
-16.03% | 16.61B | |
-0.68% | 13.62B | |
+21.87% | 11.04B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. announced that it has received $299.999996 million in funding